You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rAvPAL-PEG

Showing 26 - 50 of 884
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)

Completed
  • Mesothelioma
  • ADI-PEG 20 plus Pem Cis
  • Placebo plus Pem Cis
  • Phoenix, Arizona
  • +44 more
Sep 30, 2022

Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer Center
Sep 29, 2022

Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)

Recruiting
  • Bowel Preparation
  • Nanjing, Jiangsu, China
    A single-center, single-blind, randomized controlled clinical st
Oct 20, 2023

Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Taiwan (ADI-PEG20, Placebo)

Recruiting
  • Hepatocellular Carcinoma
  • Advanced Hepatocellular Carcinoma
  • Changhua, Taiwan
  • +8 more
Oct 19, 2022

Percutaneous Endoscopic Gastrostomy, Caregiver Burden, Mobile Application Trial in Kocaeli (mobile application ( PEG Assist ))

Recruiting
  • Percutaneous Endoscopic Gastrostomy
  • +2 more
  • mobile application ( PEG Assist )
  • Kocaeli, Turkey
    Kocaeli State Hospital
Dec 2, 2022

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

Not yet recruiting
  • PD-1 Antibody
  • +3 more
  • L-DEP and PD-1 antibody
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 8, 2023

Colonoscopy Trial in China (3 L PEG + linaclotide, 3 L PEG + )

Recruiting
  • Colonoscopy
  • 3 L PEG + linaclotide
  • 3 L PEG + placebo
  • Yinchuan, Ningxia, China
  • +7 more
Aug 10, 2022

Resectable Hepatocellular Carcinoma Trial in Houston (Nivolumab, Pegargiminase, Resection)

Recruiting
  • Resectable Hepatocellular Carcinoma
  • Nivolumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou Branch
Sep 29, 2022

Peripheral Nerve Injuries Trial in United States (NTX-001)

Not yet recruiting
  • Peripheral Nerve Injuries
  • Baltimore, Maryland
  • +6 more
Jul 27, 2022

Evaluation of Growth Hormone in Children in China(CGLS)

Recruiting
  • Childhood Short Stature
  • Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) or recombinanthuman growth hormone injection (rhGH)
  • Wuhan, Hubei, China
    TongjiHospital
Oct 31, 2023

Diagnosis and Clinical Management of Angiogenic Breast Cancer Trial in Chandigarh, New Delhi, Johannesburg (Ga-68-PEG-?vß3-IAC

Not yet recruiting
  • Diagnosis and Clinical Management of Angiogenic Breast Cancer
  • Ga-68-PEG-Αvβ3-IAC PET/CT
  • Chandigarh, India
  • +2 more
May 27, 2022

Severe Hemophilia A Trial in China (ADVATE, FRSW117)

Completed
  • Severe Hemophilia A
  • Guangzhou, Guangzhou, China
  • +3 more
Jun 27, 2022

Bowel Preparation Before Colonoscopy Trial in Wuhan (PEG, PEG+lactulose)

Completed
  • Bowel Preparation Before Colonoscopy
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Dec 18, 2022

IBD Trial in Wenzhou (3 bottles of Lactulose oral solution, 3L-polyethylene glycol)

Recruiting
  • IBD
  • 3 bottles of Lactulose oral solution
  • 3L-polyethylene glycol
  • Wenzhou, Zhejiang, China
    The Second Affiliated Hospital of Wenzhou Medical University
May 18, 2023

Bowel Cleansing; Good Taste Trial in Ningbo (Mannitol, Polyethylene glycol electrolyte)

Recruiting
  • Bowel Cleansing; Good Taste
  • Ningbo, Zhejiang, China
    Ningbo first hospital
Jun 12, 2023

Acute Lymphoblastic Leukemia Trial in Canada, United States (Doxorubicin, Cytarabine, Methotrexate)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +14 more
Jul 25, 2022

Breast Cancer Female Trial in Shanghai (MW05, PEG-rhG-CSF)

Completed
  • Breast Cancer Female
  • Shanghai, China
    Fudan University Affiliated Cancer Hospital
Dec 1, 2022

Validation of a Novel Instrument Task for Assessing Upper Limb

Recruiting
  • Assessment of Arm and Hand Sensorimotor Functions in Multiple Sclerosis Subjects
  • Assessment of the upper limb (VPIT + PPIT)
  • Valens, Saint Gallen, Switzerland
    Rehazentrum Valens
Apr 13, 2022

The Quality of Life in Individuals With Parkinson's Disease

Completed
  • Parkinson Disease
  • +2 more
  • Quality of life
  • +5 more
  • Denizli, Pamukkale, Turkey
    Pamukkale University
Jun 15, 2023

PegvisOMant and the Immune SystEm (PROMISE)

Active, not recruiting
  • Acromegaly
    • Rome, Italy
      Department of Experimental Medicine, "Sapienza" University of Ro
    Nov 6, 2022

    MS (Multiple Sclerosis), Erythema Trial in Kirkland (Warm Compress Before Injection, Cold Compress After Injection)

    Completed
    • MS (Multiple Sclerosis)
    • Erythema
    • Warm Compress Before Injection
    • Cold Compress After Injection
    • Kirkland, Washington
      Evergreen Health
    Mar 10, 2022

    Lactulose, Polyethylene Glycol, Bowel Preparation Trial in Montevideo (Lactulose, Polyethylene Glycol 3350)

    Recruiting
    • Lactulose
    • +4 more
    • Montevideo, Uruguay
      Hospital de Clinicas
    Feb 10, 2023

    High-risk Corneal Transplantation, Corneal Blindess, Corneal Inflammation Trial (CLP-PEG-MPC, Human donor cornea penetrating

    Withdrawn
    • High-risk Corneal Transplantation
    • +3 more
    • CLP-PEG-MPC
    • Human donor cornea penetrating keratoplasty
    • (no location specified)
    Dec 19, 2022